JP2004501899A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004501899A5 JP2004501899A5 JP2002505374A JP2002505374A JP2004501899A5 JP 2004501899 A5 JP2004501899 A5 JP 2004501899A5 JP 2002505374 A JP2002505374 A JP 2002505374A JP 2002505374 A JP2002505374 A JP 2002505374A JP 2004501899 A5 JP2004501899 A5 JP 2004501899A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0015601.8A GB0015601D0 (en) | 2000-06-26 | 2000-06-26 | Novel antidiuretic agents |
PCT/GB2001/002737 WO2002000626A1 (en) | 2000-06-26 | 2001-06-21 | Fused azepine derivatives and their use as antidiuretic agents |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005011930A Division JP2005104990A (ja) | 2000-06-26 | 2005-01-19 | 融合アゼピン誘導体および抗利尿剤としての使用 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2004501899A JP2004501899A (ja) | 2004-01-22 |
JP2004501899A5 true JP2004501899A5 (ja) | 2005-12-22 |
JP3935071B2 JP3935071B2 (ja) | 2007-06-20 |
Family
ID=9894399
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2002505374A Expired - Fee Related JP3935071B2 (ja) | 2000-06-26 | 2001-06-21 | 融合アゼピン誘導体および抗利尿剤としての使用 |
JP2005011930A Withdrawn JP2005104990A (ja) | 2000-06-26 | 2005-01-19 | 融合アゼピン誘導体および抗利尿剤としての使用 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2005011930A Withdrawn JP2005104990A (ja) | 2000-06-26 | 2005-01-19 | 融合アゼピン誘導体および抗利尿剤としての使用 |
Country Status (22)
Country | Link |
---|---|
US (1) | US7176195B2 (ja) |
EP (1) | EP1294698B1 (ja) |
JP (2) | JP3935071B2 (ja) |
KR (1) | KR100805808B1 (ja) |
CN (1) | CN1308313C (ja) |
AT (1) | ATE368650T1 (ja) |
AU (2) | AU2001274290B9 (ja) |
CA (1) | CA2412555A1 (ja) |
CZ (1) | CZ304037B6 (ja) |
DE (1) | DE60129697T2 (ja) |
GB (1) | GB0015601D0 (ja) |
HK (1) | HK1059780A1 (ja) |
HU (1) | HU229315B1 (ja) |
IL (1) | IL153358A0 (ja) |
MX (1) | MXPA02012779A (ja) |
NO (1) | NO324217B1 (ja) |
NZ (1) | NZ523066A (ja) |
PL (1) | PL359187A1 (ja) |
RU (1) | RU2269517C2 (ja) |
UA (1) | UA73177C2 (ja) |
WO (1) | WO2002000626A1 (ja) |
ZA (1) | ZA200300403B (ja) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7138393B2 (en) | 1998-07-24 | 2006-11-21 | Wyeth | Biologically active vasopressin agonist metabolites |
GB0000079D0 (en) | 2000-01-05 | 2000-02-23 | Ferring Bv | Novel antidiuretic agents |
GB0115515D0 (en) * | 2001-06-25 | 2001-08-15 | Ferring Bv | Oxytocin agonisys |
GB0210397D0 (en) * | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
EP2426122A1 (en) * | 2002-10-24 | 2012-03-07 | Merck Patent GmbH | Methylene urea derivative as RAF kinasse inhibitors |
CA2511970C (en) | 2003-01-14 | 2012-06-26 | Cytokinetics, Inc. | Urea derivatives useful in the treatment of heart failure |
ATE467616T1 (de) * | 2003-04-11 | 2010-05-15 | High Point Pharmaceuticals Llc | Verbindungen mit aktivität an der 11beta- hydroxasteroiddehydrogenase |
US7700583B2 (en) | 2003-04-11 | 2010-04-20 | High Point Pharmaceuticals, Llc | 11β-hydroxysteroid dehydrogenase type 1 active compounds |
US7255726B2 (en) * | 2003-05-02 | 2007-08-14 | Worcester Polytechnic Institute | Composite gas separation modules having high Tamman temperature intermediate layers |
EP1512687A1 (en) * | 2003-09-05 | 2005-03-09 | Ferring B.V. | Piperazines as oxytocin agonists |
ES2260563T3 (es) * | 2003-11-13 | 2006-11-01 | Ferring B.V. | Paquete de blister y forma farmaceutica solida para ello. |
US8110595B2 (en) | 2004-06-17 | 2012-02-07 | Cytokinetics, Inc. | Ureas and their use in the treatment of heart failure |
US7176222B2 (en) | 2004-07-27 | 2007-02-13 | Cytokinetics, Inc. | Syntheses of ureas |
EP1627876A1 (en) * | 2004-08-20 | 2006-02-22 | Ferring B.V. | Heterocyclic condensed compounds useful as antidiuretic agents |
EP1632494A1 (en) | 2004-08-24 | 2006-03-08 | Ferring B.V. | Vasopressin v1a antagonists |
JP4943858B2 (ja) * | 2004-11-17 | 2012-05-30 | キッセイ薬品工業株式会社 | 芳香族アミド誘導体、それを含有する医薬組成物およびそれらの医薬用途 |
US7538223B2 (en) | 2005-08-04 | 2009-05-26 | Cytokinetics, Inc. | Compounds, compositions and methods |
US7825120B2 (en) | 2005-12-15 | 2010-11-02 | Cytokinetics, Inc. | Certain substituted ((piperazin-1-ylmethyl)benzyl)ureas |
AR058347A1 (es) | 2005-12-15 | 2008-01-30 | Cytokinetics Inc | Entidades quimias composiciones y metodos |
US7718657B2 (en) | 2005-12-16 | 2010-05-18 | Cytokinetics, Inc. | Certain indanyl urea modulators of the cardiac sarcomere |
WO2007078839A2 (en) * | 2005-12-19 | 2007-07-12 | Cytokinetics, Inc. | Compounds, compositions and methods |
SE528446C2 (sv) * | 2006-03-02 | 2006-11-14 | Ferring Int Ct Sa | Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse |
BRPI0811204A8 (pt) * | 2007-05-10 | 2015-09-22 | Bristol Myers Squibb Co | Tetra-hidroibenzo-1,4-diazepinas substituídas por arila e heteroarila e uso das mesmas para bloquear a recaptação de norepinefrina, dopamina e serotonina |
EP2197532A1 (en) | 2007-08-06 | 2010-06-23 | Serenity Pharmaceuticals Corporation | Methods and devices for desmopressin drug delivery |
ES2596435T3 (es) * | 2008-05-21 | 2017-01-09 | Ferring B.V. | Desmopresina bucodispersable para aumentar el periodo inicial de sueño ininterrumpido por nicturia |
US11963995B2 (en) | 2008-05-21 | 2024-04-23 | Ferring B.V. | Methods comprising desmopressin |
US20100286045A1 (en) | 2008-05-21 | 2010-11-11 | Bjarke Mirner Klein | Methods comprising desmopressin |
GB201005623D0 (en) * | 2010-04-01 | 2010-05-19 | Vantia Ltd | New polymorph |
EP2681196B1 (en) * | 2011-03-04 | 2015-09-09 | Life Technologies Corporation | Compounds and methods for conjugation of biomolecules |
GB201105537D0 (en) * | 2011-03-31 | 2011-05-18 | Vantia Ltd | New process |
CN103159641A (zh) * | 2011-12-14 | 2013-06-19 | 天津泰普药品科技发展有限公司 | 托伐普坦中间体2-甲酸-5-(2-甲基苯甲酰氨基)甲苯的制备方法 |
RU2480468C1 (ru) * | 2012-02-16 | 2013-04-27 | Открытое Акционерное Общество "Международная Научно-Технологическая Корпорация" | КРИСТАЛЛИЧЕСКАЯ МОДИФИКАЦИЯ ПАРА-МЕТОКСИАНИЛИДА 6-ГИДРОКСИ-4-ОКСО-2,4-ДИГИДРО-1Н-ПИРРОЛО[3,2,1-ij]ХИНОЛИН-5-КАРБОНОВОЙ КИСЛОТЫ |
CN103373960B (zh) * | 2012-04-24 | 2017-03-01 | 江苏康缘药业股份有限公司 | 一种托伐普坦中间体及其制备方法 |
WO2020154581A1 (en) * | 2019-01-24 | 2020-07-30 | Assia Chemical Industries Ltd | Solid state forms of fedovapagon-salicyclic acid co-crystal |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5516774A (en) | 1993-07-29 | 1996-05-14 | American Cyanamid Company | Tricyclic diazepine vasopressin antagonists and oxytocin antagonists |
ATE239710T1 (de) * | 1994-06-15 | 2003-05-15 | Otsuka Pharma Co Ltd | Benzoheterocyclische derivate verwendbar als vasopressin- oder oxytocin-modulatoren |
PT1000059E (pt) * | 1997-07-30 | 2004-12-31 | Wyeth Corp | Agonistas triciclicos de vasopressina |
JP4338305B2 (ja) | 1997-07-30 | 2009-10-07 | ワイス | 三環系バソプレシンアゴニスト |
GB2355454A (en) * | 1999-10-20 | 2001-04-25 | Ferring Bv | Antidiuretic agents |
GB0000079D0 (en) | 2000-01-05 | 2000-02-23 | Ferring Bv | Novel antidiuretic agents |
-
2000
- 2000-06-26 GB GBGB0015601.8A patent/GB0015601D0/en not_active Ceased
-
2001
- 2001-06-21 DE DE60129697T patent/DE60129697T2/de not_active Expired - Lifetime
- 2001-06-21 JP JP2002505374A patent/JP3935071B2/ja not_active Expired - Fee Related
- 2001-06-21 CN CNB018118135A patent/CN1308313C/zh not_active Expired - Fee Related
- 2001-06-21 UA UA20021210560A patent/UA73177C2/uk unknown
- 2001-06-21 KR KR1020027017214A patent/KR100805808B1/ko not_active IP Right Cessation
- 2001-06-21 MX MXPA02012779A patent/MXPA02012779A/es active IP Right Grant
- 2001-06-21 CA CA002412555A patent/CA2412555A1/en not_active Abandoned
- 2001-06-21 AU AU2001274290A patent/AU2001274290B9/en not_active Ceased
- 2001-06-21 IL IL15335801A patent/IL153358A0/xx unknown
- 2001-06-21 HU HU0301339A patent/HU229315B1/hu not_active IP Right Cessation
- 2001-06-21 RU RU2003101970/04A patent/RU2269517C2/ru not_active IP Right Cessation
- 2001-06-21 WO PCT/GB2001/002737 patent/WO2002000626A1/en active IP Right Grant
- 2001-06-21 CZ CZ20024157A patent/CZ304037B6/cs not_active IP Right Cessation
- 2001-06-21 US US10/311,301 patent/US7176195B2/en not_active Expired - Fee Related
- 2001-06-21 AT AT01940792T patent/ATE368650T1/de not_active IP Right Cessation
- 2001-06-21 PL PL01359187A patent/PL359187A1/xx not_active IP Right Cessation
- 2001-06-21 NZ NZ523066A patent/NZ523066A/en not_active IP Right Cessation
- 2001-06-21 AU AU7429001A patent/AU7429001A/xx active Pending
- 2001-06-21 EP EP01940792A patent/EP1294698B1/en not_active Expired - Lifetime
-
2002
- 2002-12-18 NO NO20026094A patent/NO324217B1/no not_active IP Right Cessation
-
2003
- 2003-01-15 ZA ZA200300403A patent/ZA200300403B/xx unknown
-
2004
- 2004-04-15 HK HK04102625A patent/HK1059780A1/xx unknown
-
2005
- 2005-01-19 JP JP2005011930A patent/JP2005104990A/ja not_active Withdrawn